|
Volumn 68, Issue 4, 2007, Pages 631-632
|
Psychopharmacologic treatment response of HIV-infected patients to antipsychotic medications
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
ARIPIPRAZOLE;
ATYPICAL ANTIPSYCHOTIC AGENT;
CLOZAPINE;
CYTOCHROME P450;
CYTOCHROME P450 3A;
CYTOCHROME P450 ISOENZYME;
EFAVIRENZ;
OLANZAPINE;
PROTEINASE INHIBITOR;
QUETIAPINE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RISPERIDONE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ZIPRASIDONE;
AGRANULOCYTOSIS;
ATHEROSCLEROSIS;
CEREBROVASCULAR ACCIDENT;
CORONARY ARTERY DISEASE;
DIABETES MELLITUS;
DISEASE EXACERBATION;
DYSLIPIDEMIA;
EXTRAPYRAMIDAL SYMPTOM;
GLUCOSE INTOLERANCE;
HEART INFARCTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERSALIVATION;
IMPAIRED GLUCOSE TOLERANCE;
INSULIN RESISTANCE;
KIDNEY FUNCTION;
LIPODYSTROPHY;
LIVER FUNCTION;
MANIA;
METABOLIC SYNDROME X;
NEUTROPENIA;
PRIORITY JOURNAL;
PSYCHOPHARMACOLOGY;
PSYCHOSIS;
SEDATION;
SHORT SURVEY;
SIDE EFFECT;
TREATMENT DURATION;
TREATMENT RESPONSE;
VIRUS LOAD;
|
EID: 34247501646
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: 10.4088/jcp.v68n0421 Document Type: Short Survey |
Times cited : (7)
|
References (18)
|